Результаты поиска

Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol.

IntroductionFinancial toxicity (FT) is a well-recognised problem in oncology. US-based studies have shown that: (a) cancer patients have a 2.7 times risk of bankruptcy; (b) patients who declare bankruptcy have a 79% greater hazard of death; (c) financial burden significantly impairs quality of life (QoL) and (d) reduces compliance and adherence to treatment prescriptions. The aim of the project is to develop and validate a patient-reported-outcome (PRO) measure to assess FT of cancer patients in Italy, where, despite the universal health coverage provided by the National Health Service, FT is

'I think it affects every aspect of my life, really': Cancer survivors' experience of living with chronic pain after curative cancer treatment in England, UK.

AimTo explore cancer survivors' experiences of living with chronic pain after curative cancer treatment in England, UK.MethodsA qualitative study using telephone interviews with adult cancer survivors experiencing chronic pain after curative cancer treatment. Interview data was analysed using a reflexive thematic approach [1-3].FindingsNineteen participants: 14 female, 5 male, mean age 62.4 years, 1.5-48 years since cancer diagnosis, eight tumour groups represented. Six participants (31.6%) developed chronic pain more than ten years after completing cancer treatment (range 0-25 years). Five th

Совпадение в полном тексте источника
… for Rheumatic Diseases (RNHRD), Bath, (now known as the Pain-related Cancer Late Effects Functional Rehabilitation Service, Royal United Hospitals NHS Foundation Trust, Bath, UK)—an NHS cancer late effects service https://www.crpsandcancerlateeffects-bath.org.uk/ 2) Penny Brohn UK, a national cancer charity … The leaflet contained contact details of the research team and advice about where to access support, such as national cancer charities. Interviews were digitally audio-recorded and transcribed verbatim by university-approved professional transcription services. …

Характеристика разнообразия многочисленных склерозных популяций в Канаде: обзор аналитического исследования.

СПРАВОЧНАЯ ИНФОРМАЦИЯ: Цель этого аналитического обзора заключалась в выявлении существующей информации и пробелов в знаниях, касающихся характеристик разнообразия групп населения склероза (МС) в Канаде. МЕТОДЫ: Мы искали MedLINE, EMBASE, Cumsted Index in Medsing and Alimate Health Lification (CINAHL), SCOPUS and ProQuest's глобальный набор данных и диссертаций с 2010 года по 12 января 2024 года. Источниками данных являются тематические доклады/серии, когортные исследования, исследования по контролю за конкретными случаями, аналитические перекрестные исследования, случайные клинические испытан

The role of the bone microenvironment in regulating myeloma residual disease and treatment.

Multiple myeloma is an incurable haematological cancer. The increase in targeted therapies has improved the number of myeloma patients achieving a complete response and improved progression-free survival following therapy. However, a low level of disease or minimal residual disease (MRD) still persists which contributes to the inevitable relapse in myeloma patients. MRD has been attributed to the presence of dormant myeloma cells and their subsequent reactivation, which is controlled by the microenvironment and specialised niches within the bone marrow. This contributes to the evasion of the i

Association of genetic variants with patient reported quality of life and pain experience in patients in the UK NCRI Myeloma X Relapse [Intensive]) trial; an exploratory study.

The Myeloma X trial provided a platform to explore genetics in relation to systematic assessment of patient-reported outcomes at key points during salvage treatment in multiple myeloma (MM) patients. Blood DNA was obtained in 191 subjects for single nucleotide polymorphism (SNP) genotyping. By univariable analysis, the non-coding rs2562456 SNP, upstream of LINC00664, was associated with several relevant pain and health-related quality-of-life (HRQoL) scores at 100 days after allocation to consolidation with autologous stem cell transplantation or weekly cyclophosphamide. Presence of the minor

Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals.

BackgroundOne of the functions of the reformed Cancer Drugs Fund in England is as a managed access fund, providing conditional funding for cancer drugs where there is uncertainty in the economic case, and where that uncertainty can be addressed by data collection during two years' use in the NHS. Our study characterises likely sources of such uncertainty, through a review of recent NICE Technology Appraisals.MethodsDiscussions of uncertainty in NICE Appraisal Committees were extracted from published Single Technology Appraisals of cancer drugs, 2014-2016, and categorised inductively. The locat

Совпадение в полном тексте источника
… Open Access publishing is funded by the UK Charities Open Access Fund allocation to the University of Oxford. Availability of data and materials The datasets supporting the conclusions of this article are available from the corresponding author on reasonable request. …

Clinical utility and patient consideration in the use of lenalidomide for multiple myeloma in Chinese patients.

Multiple myeloma (MM) is an incurable hematologic malignancy caused by the autonomous growth of malignant plasma cells. In the last decade, the introduction of novel targeted agents such as thalidomide, bortezomib, and lenalidomide has dramatically improved the clinical outcome of MM patients in both the frontline and recurrent settings. Lenalidomide is a synthetic derivative of thalidomide, which has been shown to significantly improve overall survival, time to progression, and overall response rates in patients with MM. The China Food and Drug Administration approved the use of lenalidomide

Proceedings of Patient Reported Outcome Measure's (PROMs) Conference Oxford 2017: Advances in Patient Reported Outcomes Research : Oxford, UK. 8th June 2017.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Совпадение в полном тексте источника
… Methods: A partnership approach to implementation was adopted; a collaboration between a charity (ARUK), researchers and n = 10 partners providing a range of MSK services. Interim interviews were conducted over a one year period to share emerging experiences, successes and challenges. … Conclusion: Despite some challenges, the MSK-HQ appears to be acceptable, feasible and useful for clinical decision making Partnership between charities, academics and local NHS services are a promising mechanism to implement PROMs. …

метрики МРТ, полученные с помощью АИ, у пациентов с множественной миэломой обнаруживают уникальное понимание состава и исхода тела.

Аббревиатры с множественной миеломой часто подвергаются длительному, многолинейному и многонаркологическому лечению, что может существенно повлиять на общее состояние здоровья, физический запас и физиологическая устойчивость. Представление органов, которые запечатлены с помощью сканирования всего тела, может быть подвергнуто оппортунистическиму допросу для получения прямых количественных показателей состава тела. Достижения и стандартизация магнитно-резонансной съемки всего тела (WBMRI) наряду с недавними усовершенствованиями в методологиях искусственного интеллекта (AI) для автоматизированной

Psychobiographical Reflections on Marilyn Yalom's Experience of Death and Dying.

The universal awareness of death is central to the framework of existential psychology. However, its subjective confrontation remains deeply personal. Marilyn Yalom (1938-2019), distinguished feminist scholar and cultural historian, documented her intimate reflections on dying in a book co-authored with her husband, Irvin Yalom, renowned existential psychotherapist and author. This single-case psychobiography sought to examine her experience, focusing on her diarised reflections on living with and dying from a terminal illness in this book as the primary data source. Data analysis examined Mar

The Economic Burden of Cancer in Canada from a Societal Perspective.

Cancer patients and their families experience considerable financial hardship; however, the current published literature on the economic burden of cancer at the population level has typically focused on the costs from the health system's perspective. This study aims to estimate the economic burden of cancer in Canada from a societal perspective. The analysis was conducted using the OncoSim-All Cancers model, a Canadian cancer microsimulation model. OncoSim simulates cancer incidence and deaths using incidence and mortality data from the Canadian Cancer Registry and demography projections from

Codesigning a supportive online resource for Australian cancer carers: a thematic analysis of informal carers' and healthcare professionals' perspectives about carers' responsibilities and content needs.

ObjectiveTo gather preliminary qualitative data that will assist in the codesign and development of a new informational and supportive website to assist informal cancer carers in Australia.Design and settingUtilising a previously tested codesign process, informal carers' experiences and perspectives, including those of healthcare professionals', were examined via focus groups and/or interviews. Data were analysed via thematic analysis.ParticipantsRural (n=9) and urban (n=11) carers', and healthcare professionals' (n=8) perspectives were collected. Carers participated in a focus group (n=9) or

Exploring the rationale, experience and impact of using Cancer Information and Support (CIS) services: an international qualitative study.

PurposeThe aim of this study was to develop an in-depth understanding of the rationale, experiences, evaluation and outcomes of using Cancer Information and Support (CIS) services in Australia, the UK and USA.MethodsSemi-structured interviews were used to gather data between November 2015 and January 2016. Telephone interviews were recorded, de-identified, transcribed and thematically analysed. Ten users from each of three international CIS services (n = 30 in total) were recruited. Participants were eligible for inclusion if they had utilised the CIS in 2015 via telephone contact with a cance

Совпадение в полном тексте источника
… These services are predominantly offered by organisations that sit alongside, but are separate to, health services and include non-government organisations and charities including cancer societies. …

метрики соотношений на основе пропорциональности при подсчете данных о составе.

Составные данные включают векторы, описывающие составные части целого. Данные, полученные с помощью различных -омикических платформ, таких, как 16S и RNA, носят составный характер. В таких данных корреляции между характеристиками первичных счетов не имеют сколько-нибудь значимого толкования. Для решения этой проблемы были сформулированы критерии пропорциональности. Однако имманентная погрешность возникает тогда, когда эти метрики рассчитываются эмпирически на основе показателей, основанных на подсчете, из-за изменчивости глубин считываемого материала. Мы подсчитали погрешность, введенная путем

Nirogacestat-the pathway to approval of the first treatment for desmoid tumors, a rare disease.

Drug development for rare diseases can be long, complex, and costly. Desmoid tumors (DT), a rare type of soft-tissue tumor, are associated with substantial and debilitating burden, including disease-specific symptoms (e.g., pain, impaired mobility), reduce functioning for daily activities, and worsen quality of life for patients with this condition. These tumors can be potentially life-threatening when they invade surrounding tissues, affect vital structures, or interfere with the body's functions. Until recently, there were no approved treatments specific to DT and little alignment on disease

Strengths and opportunities to clinical trial enrollment among BIPOC, rural dwelling patients in the northwest United States: a retrospective study.

Introduction: Clinical trials investigating the safety and efficacy of experimental drugs and devices are the cornerstone of medicinal advancement. Enrolling sufficient participants in these trials is vital to ensure adequate statistical power and generalizability. Clinical trial participation is particularly low among certain populations, including medically underserved communities (i.e., rural areas) and Black, Indigenous, and People of Color (BIPOC). Methods: A retrospective study design was used to understand patient outcomes and access/barriers to clinical trial participation in the rural

Caregiver's quality of life in advanced cancer: validation of the construct in a real-life setting of early palliative care.

IntroductionEarly palliative care (EPC) improves the quality of life (QoL) of advanced cancer patients and their caregivers. The increasingly widespread use of this care model requires the development of measures supporting its interventions. Although the construct of patient's QoL has been extensively investigated and several QoL measures have been further validated, there is a paucity of data concerning the QoL of the caregiver. In 2018, McDonald and colleagues addressed this issue by interviewing 23 primary caregivers of advanced cancer patients who participated in an EPC randomized clinica

Outcome Prediction of Hematologic Malignancy in Critically Sick People.

People with hematologic malignancies (HM) frequently postulate intensive care unit (ICU) hospitalization due to organ damage caused by the disease process or treatment-related consequences. This study is aimed at looking at mortality and sign factors in adult patients with hematologic malignancy (HM) who have been hospitalized in the ICU. Death was one quality indicator; researchers used a machine learning approach to find determinants of death. As per the study, there have been 206 patients hospitalized in the ICU (mean age: 51.3 ± 13.6 years; 60% male). The average length of stay was three d

Совпадение в полном тексте источника
… Decision trees, Bayesian networks, artificial neural networks, and support vector machines are among the approaches extensively used in cancer charities to construct forecasting designs, resulting in reliable and time-made decisions. …

Клинические и лабораторные характеристики и методы лечения пациентов, у которых диагностирована миелома: реальная группа пациентов в перуанской поликлинике.

Множественная миелома (ММ) — злокачественное распространение клеток клональной плазмы, вызывающее повреждения костей, почечную недостаточность, анемию и гиперкальцемию. Реальные данные о клинических характеристиках, методах лечения и результатах лечения пациентов с ММ в Латинской Америке, особенно в Перу, по-прежнему являются недостаточными. Цель этого исследования состояла в том, чтобы описать клинические и лабораторные характеристики, характеристики, методы и методы лечения. 5-year Выживание пациентов ММ в перуанской клинике. Мы провели ретроспективное когортное исследование с участием взрос

CAR-T in relapsed refractory high-grade glioma and glioblastoma - who, what, when and how?

Recurrent high-grade gliomas have a dismal prognosis. This review article aimed to explore and help answer the questions about which group of patients would benefit from chimeric antigen receptor therapy (CAR-T) cell therapy in this setting, the timing of intervention and the therapeutic efficacy. CAR-T cell therapy involves the extraction of T-cells from patients, genetic modification of these cells to express chimeric antigen receptors on their cell surface, which are selectively targeted towards tumour-expressed antigens and a procedure of immune-depletion followed by re-introducing these e